Innovating Works

PRIOHealth

Financiado
Presidency event - Belgium. R&I policies for Better Health, Wellbeing and Prospe...
Presidency event - Belgium. R&I policies for Better Health, Wellbeing and Prosperity : Policy for Research and InnOvation for better HEALTH Europe is confronted with a multitude of health challenges for which strong research and innovation efforts may bring solutions. The strategies and policies governing R&I, however, need to be harmonized across different levels (EU... Europe is confronted with a multitude of health challenges for which strong research and innovation efforts may bring solutions. The strategies and policies governing R&I, however, need to be harmonized across different levels (EU, national, regional) and transcend geographical boundaries to defragment European research efforts. The need for European cross-border alignment of R&I efforts became particularly obvious during the COVID pandemic. Although there is an immense potential throughout Europe to become the preferred global hub to conduct clinical studies and trials, Europe largely failed to secure this potential. Besides the imminent urgency to provide a response in case of a pandemic, aligning R&I strategies and policies isalso crucial to develop healthcare of the future, which will be personalised and preventive, building on the convergence of cutting-edge technologies, such as bio-, nano-, digital technologies and engineering and integration of several types of data, including genomic data, health data, and real-world data. The transformative potential of such convergence, however, is frequently hindered by the challenge of translating scientific knowledge into practical innovations and effectively incorporating these innovations into healthcare systems as well as the lack of standardisation and harmonisation. The European partnerships and access to high-end research infrastructures play a pivotal role in addressing the fragmentation of European R&I efforts and realising the ultimate goals and ambitions of establishing Europe as a lead region in the world providing R&I-based answers to complex health challenges. ver más
28/02/2025
VL O
492K€
Perfil tecnológico estimado
Duración del proyecto: 11 meses Fecha Inicio: 2024-03-12
Fecha Fin: 2025-02-28

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-12
Presupuesto El presupuesto total del proyecto asciende a 492K€
Líder del proyecto
VLAAMSE GEWEST No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5